Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC	mCRPC	Active, not recruiting	Phase 3	2026-09-29		NCT03395197

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Astellas Pharma Inc	43
Pfizer	431

370 results · Page 1 of 15

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
A.Z. Sint-Lucas	Ghent	Belgium	1
AdventHealth Medical Group Hermatology and Oncology	Orlando	United States	1
Akershus University Hospital	Lorenskog	Norway	3
Alaska Urological Institute dba Alaska Clinical Research Center	Anchorage	United States	3
AMITA Health Adventist Medical Center Hinsdale	Hinsdale	United States	2
AMITA Health Cancer Institute	Hinsdale	United States	1
AOU San Luigi Gonzaga	Orbassano	Italy	1
Arizona Urology Specialists	Tucson	United States	6
Arizona Urology Specialists	Tucson	United States	5
Arthur J.E Child Comprehensive Cancer Centre	Calgary	Canada	3
Asan Medical Center	Seoul	South Korea	338
Associacao Hospital de Caridade de Ijui	Ijuí	Brazil	1
Associated Medical Professionals of New York, PLLC	Syracuse	United States	3
ASST di Cremona	Cremona	Italy	1
Auckland City Hospital	Auckland	New Zealand	68
AZ Groeninge	Kortrijk	Belgium	53
AZ KLINA	Brasschaat	Belgium	17
Azienda Ospedaliera S. Maria	Terni	Italy	1
Azienda Ospedaliero-Universitaria Policlinico Sant' Orsola Malpighi	Bologna	Italy	1
Azienda sanitaria universitaria integrata del Trentino (ASUIT) - Ospedale Santa Chiara	Trento	Italy	1
Baylor Scott & White Medical Center - Temple	Temple	United States	13
Beijing Cancer Hospital	Beijing	China	208
Beijing Hospital	Beijing	China	4
Beverly Hills Cancer Center	Beverly Hills	United States	26
Cancer Center Clinical Trial, Asan Medical Center	Seoul	South Korea	1

Clinical trials